HIV/AIDS Clinical Trial
Official title:
The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent Girls
The study will use focus group methodology in the formative evaluation phase. Focus group methodology provides a rich source of data and understanding of phenomena by allowing the researcher to examine the interaction among participants
Status | Not yet recruiting |
Enrollment | 10 |
Est. completion date | August 2025 |
Est. primary completion date | June 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 13 Years to 18 Years |
Eligibility | Inclusion Criteria 1. Identify as a Black/African American female 2. Be between the ages of 13-18 years old; 3. Consent to being a part of the study (Parent consent and youth assent if under 18 years old); 4. Live in Paterson, New Jersey at the time of the study; 5. English as their first language. Exclusion Criteria 1. not identify as Black/African American only 2. be under the age of 13 or over the age of 18 3. no parental consent provided 4. no youth assent provided 5. does not live in Paterson 6. does not read, speak or write in English 7. is currently pregnant |
Country | Name | City | State |
---|---|---|---|
United States | Paterson Youth Services Bureau | Paterson | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Yale University | National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in 30-day drug use | Past 30-day drug use will be measured using items from the National Survey on Drug Use and Health (Substance Abuse and Mental Health Services Administration, 2006) and Youth Risk Behavior Survey. The scale consisted of three items that assesses how often participants smoked cigarettes, drank alcohol, and smoked marijuana in the past 30 days. An example of an item is, "Estimate the number of days you used marijuana or hashish in the last 30 days." Participants responded to these items on a 7-point scale (1 = 0 days; 2 =1-2 days, 3 = 3-5 days; 4 = 6-9 days; 5 = 10-19 days; 6 = 20-29 days; 7 = All 30 days). The sum of this scale is the mean of responses on the three items, with higher scores indicating greater frequency of use. | 30 days | |
Primary | Change in perception of drug use risk | To assess the perceived risk of using alcohol, tobacco, and marijuana, adapted questions from the Monitoring the Future study will be used. Questions such as: perceived risk of moderate daily drinking, heavy drinking, combining alcohol with marijuana, daily smoking and heavy, daily and heavy marijuana use. The choices are: 0=Can't Say/Drug Unfamiliar, 1=No risk, 2=Slight risk, 3=Moderate risk, 4=Great risk. All of the items will be summed together. Higher score indicates greater perception of risk from using alcohol and drugs | Baseline, 30 days, 60 days | |
Primary | Change in perception of sexual risk | Perception of Sexual Risk was assessed using eight items that measured participants' perception of sexual risk (sample item: How much do you think people risk harming themselves physically if they have sex without a condom or dental dam?) and substance use risk (sample item: How much do people risk harming themselves physically or in other ways when they smoke marijuana once or twice a week?). Items will be summed and higher scores will indicate greater perceived risk | Baseline, 30 days, 60 days | |
Primary | Change in HIV knowledge | HIV Knowledge will be assessed using eight items that measured participants' HIV knowledge (sample item: Only people who look sick can spread the HIV/AIDS virus.). Responses were recorded using True (1) or False (0). Items will be summed and higher scores indicated greater HIV knowledge | Baseline, 30 days, 60 days | |
Primary | Change in sexual risk behavior | Sexual Risk Behavior: Six items will be adapted from the National Youth Risk Behavior Survey , which assess sexual behavior among high school aged adolescents. These items included: having ever had vaginal sex, how many times participants had sex in the past 3 months, number of lifetime sexual partners, age of first sexual intercourse, having sex under the influence of drugs and alcohol, and having unprotected sex without a condom. A composite score will be used where the range of score is 0 to 30, the higher the score the more perception of risk | Baseline, 30 days, 60 days | |
Primary | Change in ethnic identity | Multigroup Ethnic Identity Measure (MEIM) Revised consists of six questions and will be used to measure ethnic identity. Responses using a 4-point Likert-type scale will range from Strongly disagree (1) to Strongly agree (4). Scores were totaled by summing responses, with higher scores representing greater ethnic identification (Cronbach a = .86). Responses on the original MEIM ranged from 20 to a maximum of 80. | Baseline, 30 days, 60 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Completed |
NCT03923231 -
Pharmacokinetics of Atazanavir in Special Populations
|